Mood/Sleep/Inflammation

CBG

Non-psychoactive hemp cannabinoid studied for anxiety, sleep, and pain relief, though human clinical evidence remains preliminary.

CBG

Non-psychoactive hemp cannabinoid studied for anxiety, sleep, and pain relief, though human clinical evidence remains preliminary.

score

evidence

Caution

risk

Overview

Forms

Safety

Stack

Quick Take

Skip for now unless you are participating in a clinical trial — human evidence is too early to rely on.

Cannabigerol (CBG) is a non-intoxicating cannabinoid found in cannabis and hemp plants, not ordinary foods, usually in low amounts because it converts into other cannabinoids as the plant matures. It interacts with CB1/CB2 receptors, TRP channels, and endocannabinoid pathways that may influence pain and inflammation. Early human surveys and small studies suggest possible benefits for anxiety, sleep, and chronic pain, but robust randomized trials are still lacking. Interest is highest among adults already using cannabinoids under medical guidance or people seeking non-intoxicating hemp products

Proven Benefits

May reduce anxiety

May improve sleep quality

May ease chronic pain

Protocol

Amount

5-25 mg

Frequency

Once or twice daily

When

With food to improve absorption and reduce stomach upset; evening if using for sleep.

Onset Time

Variable; acute effects, if any, are usually felt within 1-3 hours.

Who Should Consider

Adults using cannabinoids under medical guidance

People in clinical cannabinoid studies

Those seeking non-intoxicating hemp compounds

How It Works

CBG appears to modulate CB2 more than CB1 and also interacts with TRPV1, TRPA1, and alpha-2 adrenergic receptors involved in pain and autonomic signaling. It may also influence endocannabinoid tone by affecting anandamide transport or breakdown, but most evidence comes from cell and animal studies.

Updated Invalid Date